BUSINESS

Jazz Pharmaceuticals Buys Actio Biosciences for $1.32B

Jazz Pharmaceuticals is acquiring Actio Biosciences in a $1.32 billion deal, expanding its pharmaceutical portfolio.

SeekingAlpha
EDITOR'S PICKS

Markets

View all 6 →

Economy

View all 1 →

Business

View all 6 →

Personal Finance

View all 3 →
MOST READ
  1. 1 BUSINESS

    Jazz Pharmaceuticals Buys Actio Biosciences for $1.32B

  2. 2 BUSINESS

    OpenGate Capital to Acquire Maersk's Global Safety Training Unit

  3. 3 PERSONAL FINANCE

    HELOC vs. Home Equity Loan Rates: What to Know Today

  4. 4 MARKETS

    What Bitcoin's BIP-110 Debate Tells Us About Crypto Markets

  5. 5 BUSINESS

    GameStop Eyes eBay Collaboration Instead of Full Takeover

Stay informed.

One concise briefing, weekly. No spam.

By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.